Login to Your Account



Merrimack wins FDA approval for pancreatic cancer drug Onivyde

By Michael Fitzhugh
Staff Writer

Thursday, October 22, 2015

Two days earlier than expected, the FDA approved Merrimack Pharmaceuticals Inc.’s Onivyde in combination with fluorouracil and leucovorin, for patients with advanced pancreatic cancer.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription